ATE521697T1 - Verfahren zum wachstum von menschlichen bindehautgewebeäquivalenten für die forschung, die klinische augenoberflächentransplantation und die geweberekonstruktion - Google Patents

Verfahren zum wachstum von menschlichen bindehautgewebeäquivalenten für die forschung, die klinische augenoberflächentransplantation und die geweberekonstruktion

Info

Publication number
ATE521697T1
ATE521697T1 AT03721475T AT03721475T ATE521697T1 AT E521697 T1 ATE521697 T1 AT E521697T1 AT 03721475 T AT03721475 T AT 03721475T AT 03721475 T AT03721475 T AT 03721475T AT E521697 T1 ATE521697 T1 AT E521697T1
Authority
AT
Austria
Prior art keywords
tissue
equivalents
research
eye surface
human connective
Prior art date
Application number
AT03721475T
Other languages
English (en)
Inventor
Donald Tan
Leonard Ang
Roger Beuermann
Original Assignee
Singapore Eye Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Singapore Eye Res Inst filed Critical Singapore Eye Res Inst
Application granted granted Critical
Publication of ATE521697T1 publication Critical patent/ATE521697T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C12N2500/14—Calcium; Ca chelators; Calcitonin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C12N2500/84—Undefined extracts from animals from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
    • C12N2533/92—Amnion; Decellularised dermis or mucosa
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AT03721475T 2002-03-29 2003-03-28 Verfahren zum wachstum von menschlichen bindehautgewebeäquivalenten für die forschung, die klinische augenoberflächentransplantation und die geweberekonstruktion ATE521697T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36815802P 2002-03-29 2002-03-29
PCT/US2003/009392 WO2003084431A2 (en) 2002-03-29 2003-03-28 Method for growth of human conjunctival tissue equivalents for research, clinical ocular surface transplantation and tissue engineering

Publications (1)

Publication Number Publication Date
ATE521697T1 true ATE521697T1 (de) 2011-09-15

Family

ID=28791886

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03721475T ATE521697T1 (de) 2002-03-29 2003-03-28 Verfahren zum wachstum von menschlichen bindehautgewebeäquivalenten für die forschung, die klinische augenoberflächentransplantation und die geweberekonstruktion

Country Status (7)

Country Link
US (2) US7049139B2 (de)
EP (1) EP1499710B1 (de)
CN (1) CN1649998A (de)
AT (1) ATE521697T1 (de)
AU (1) AU2003224785B2 (de)
HK (1) HK1080111A1 (de)
WO (1) WO2003084431A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003224785B2 (en) * 2002-03-29 2008-12-11 Singapore Eye Research Institute Method for growth of human conjunctival tissue equivalents for research, clinical ocular surface transplantation and tissue engineering
CN1720055A (zh) * 2002-10-04 2006-01-11 组织技术公司 视网膜上皮细胞在羊膜上的培养和移植
DE102005027355A1 (de) * 2005-06-13 2006-12-14 Femtotechnologies Gmbh Verfahren zum Bearbeiten eines organischen Materials
EP1987133A2 (de) * 2006-02-24 2008-11-05 Reliance Life Sciences Pvt., Ltd. Augeninnengewebesystem
US8372437B2 (en) 2006-08-17 2013-02-12 Mimedx Group, Inc. Placental tissue grafts
JPWO2008105454A1 (ja) 2007-02-28 2010-06-03 千寿製薬株式会社 ラクリチン高発現細胞
US8574567B2 (en) 2007-05-03 2013-11-05 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
EP2155860B1 (de) 2007-05-03 2014-08-27 The Brigham and Women's Hospital, Inc. Multipotente stammzellen und ihre verwendung
EP2151492B1 (de) * 2007-05-11 2015-03-04 Dai Nippon Printing Co., Ltd. Zellschicht mit guter dimensionaler stabilität, verfahren zu ihrer herstellung und zellkulturträger zur verwendung für das verfahren
EP3189731B1 (de) 2007-09-07 2020-01-29 MiMedx Group, Inc. Plazentale gewebetransplantate und verfahren zur herstellung und verwendung davon
EP2225361A1 (de) * 2007-11-28 2010-09-08 Organogenesis, Inc. Biotechnisch konstruierte gewebekonstrukte und verfahren zur herstellung und verwendung
CN104263699A (zh) * 2014-09-19 2015-01-07 江苏华亿细胞组织工程有限公司 细胞移植用临床治疗级真皮多能干细胞规模化制备培养方法
CN104312970A (zh) * 2014-09-19 2015-01-28 朱宁文 一种细胞治疗用临床治疗级表皮干细胞应用人类细胞外基质筛选及规模化培养制备方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3249504A (en) 1962-03-13 1966-05-03 Becton Dickinson Co Multiple unit tissue culture preparation and method of preparing same
US4456687A (en) 1978-11-16 1984-06-26 President And Fellows Of Harvard College Agents for promoting growth of epithelial cells
US4443546A (en) 1980-07-07 1984-04-17 The Beth Israel Hospital Association Process and composition for propagating mammalian cells
US5166048A (en) 1981-03-02 1992-11-24 Soll David B Protection of human corneal endothelial cells
US4423145A (en) 1981-05-07 1983-12-27 Stampfer Martha R Enhanced growth medium and method for culturing human mammary epithelial cells
US4940666A (en) 1983-07-15 1990-07-10 University Patents, Inc. Process and defined medium for growth of human epidermal keratinocyte cells
US4673649A (en) 1983-07-15 1987-06-16 University Patents, Inc. Process and defined medium for growth of human epidermal keratinocyte cells
US5976878A (en) * 1987-04-28 1999-11-02 The Regents Of The University Of California Method and apparatus for preparing composite skin replacement
DE3801236A1 (de) 1988-01-18 1989-07-27 Boehringer Mannheim Gmbh Pentosansulfat-medium
GB8803697D0 (en) 1988-02-17 1988-03-16 Deltanine Research Ltd Clinical developments using amniotic membrane cells
AU621972B2 (en) 1988-12-14 1992-03-26 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Cell culture medium for human liver epithelial cell line
CA2018228C (en) 1989-06-05 1996-02-27 Nancy L. Parenteau Cell culture systems and media
US5292655A (en) 1990-01-29 1994-03-08 Wille Jr John J Method for the formation of a histologically-complete skin substitute
US5834312A (en) * 1990-01-29 1998-11-10 Hy-Gene, Inc. Process and media for the growth of human epithelia
US5328844A (en) 1990-05-09 1994-07-12 University Of Colorado Foundation, Inc. Culture media for mammalian cells
US5811094A (en) 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
JPH0789908B2 (ja) * 1991-02-28 1995-10-04 倉敷紡績株式会社 動物細胞培養用無血清培地
US6045791A (en) 1992-03-06 2000-04-04 Photogenesis, Inc. Retinal pigment epithelium transplantation
DE4401606A1 (de) * 1994-01-20 1995-07-27 Wacker Chemie Gmbh Hitzestabilisierte, zu Elastomeren vernetzbare Organopolysiloxanmassen
US5405772A (en) 1993-06-18 1995-04-11 Amgen Inc. Medium for long-term proliferation and development of cells
US5610281A (en) * 1994-05-03 1997-03-11 Brigham & Women's Hospital, Inc. Antibodies for modulating heterotypic E-cadherin interactions with human T lymphocytes
US5610699A (en) 1994-07-12 1997-03-11 Xerox Corporation Photoreceptor cleaning apparatus and method
US5650279A (en) * 1995-01-27 1997-07-22 Allergan, Inc. Gene sequence induced in skin by retinoids
US6043092A (en) 1996-03-18 2000-03-28 University Of Pittsburgh Cell culture media for mammalian cells
CA2216439A1 (en) 1996-09-25 1998-03-25 Derek Van Der Kooy Pharmaceuticals containing retinal stem cells
US6152142A (en) * 1997-02-28 2000-11-28 Tseng; Scheffer C. G. Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
US5972332A (en) * 1997-04-16 1999-10-26 The Regents Of The University Of Michigan Wound treatment with keratinocytes on a solid support enclosed in a porous material
US5932205A (en) 1997-07-24 1999-08-03 Wang; Ming X. Biochemical contact lens for treating photoablated corneal tissue
US6143315A (en) 1997-07-24 2000-11-07 Wang; Ming X. Biochemical contact lens for treating injured corneal tissue
US20020039788A1 (en) * 2000-02-29 2002-04-04 Isseroff Roslyn R. Corneal epithelial graft composites
US7052690B2 (en) * 2000-10-05 2006-05-30 The Schepens Eye Research Institute, Inc. Culture of goblet cells
AU2003224785B2 (en) * 2002-03-29 2008-12-11 Singapore Eye Research Institute Method for growth of human conjunctival tissue equivalents for research, clinical ocular surface transplantation and tissue engineering

Also Published As

Publication number Publication date
US20040009590A1 (en) 2004-01-15
EP1499710B1 (de) 2011-08-24
AU2003224785B2 (en) 2008-12-11
HK1080111A1 (zh) 2006-04-21
US7049139B2 (en) 2006-05-23
WO2003084431A3 (en) 2004-04-15
CN1649998A (zh) 2005-08-03
WO2003084431A2 (en) 2003-10-16
US7611895B2 (en) 2009-11-03
AU2003224785A1 (en) 2003-10-20
EP1499710A4 (de) 2005-08-31
US20060177927A1 (en) 2006-08-10
EP1499710A2 (de) 2005-01-26

Similar Documents

Publication Publication Date Title
HK1080111A1 (zh) 為研究、臨床眼晴表面移植和組織工程的應用而生長人類結膜組織等同物的方法
JP4335873B2 (ja) 再生角膜内皮細胞シート、製造方法及びその利用方法
ATE359358T1 (de) Verfahren und medien zur kontrolle der sialysierung von proteinen, die von säugetierzellen produziert werden
ATE407138T1 (de) Verfahren zur herstellung interferierender rna- moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
DE50112855D1 (de) Verfahren zur Herstellung von Knorpelimplantaten mittels in vitro gezüchteter Chondrozyten
ATE430807T1 (de) Verfahren zur kultivierung von circovirus
ATE539145T1 (de) Verfahren zum erhalt von mesenchymalen stammzellen
EP2446892A3 (de) Isolierte adulte pluripotente Stammzellen und Verfahren zu deren Isolierung und Kultivierung
ATE489456T1 (de) Menschliche hornhautendothelzellen und verfahren zur gewinnung und kultivierung von zellen zur hornhautzelltransplantation
DE60044690D1 (de) Verfahren zur Herstellung von rekombinanten Proteinen mittels Inhibitoren von Apoptose
SG171577A1 (en) Methods for producing yeast-based vaccines
ATE493203T1 (de) Verfahren und gerät zur herstellung von genetisch transformierbarem pflanzengewebe
UA92157C2 (ru) Способ продуцирования гормона роста
ATE510004T1 (de) In-vitro-techniken zur verwendung mit stammzellen
ATE479743T1 (de) Verfahren zur herstellung von zellkulturen aus biologischen präparaten für chemotherapeutische und andere assays
DE602004006299D1 (de) Verwendung eines hydrogels zum züchten von chondrozyten
HUP0302600A2 (hu) Eljárás petefészektüszők in vitro tenyésztésére
ATE354642T1 (de) Methoden und medium zur in vitro-kultivierung von menschlichen embryos
Schneider et al. Differentiating the stem cell pool of human hair follicle outer root sheath into functional melanocytes
TW200506059A (en) Method for obtaining mastocyte lines from pig tissues and for producing heparin-type molecules
ATE414760T1 (de) Verfahren zur herstellung einer epithelzellen enthaltenden zellzusammensetzung
DE60120676D1 (de) Verfahren zur entwicklung von epithelialen stammzellen
Bissiere et al. Cell fate decisions during preimplantation mammalian development
WO2001005942A3 (en) Improved keratinocyte culture and uses thereof
WO2007075796A3 (en) Stage specific follicle maturation systems

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties